This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Oncotherapy Science, Incorporated. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Aiko Kudo: Innovator in Cancer Therapy
Introduction
Aiko Kudo is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of cancer therapy through her innovative research and development of anti-CDH3 antibodies. Her work is particularly relevant in the treatment of various types of cancer, including pancreatic, lung, colon, prostate, breast, gastric, and liver cancers.
Latest Patents
Aiko Kudo holds a patent for "Anti-CDH3 antibodies and uses thereof." This invention relates to anti-CDH3 antibodies that can be labeled with a radioisotope. The patent also provides methods and pharmaceutical compositions that include an anti-CDH3 antibody as an active ingredient. This innovation is crucial for developing therapies targeting cancer cells that express CDH3.
Career Highlights
Aiko Kudo is associated with Oncotherapy Science, Incorporated, where she continues to advance her research in cancer therapies. Her dedication to improving treatment options for cancer patients has positioned her as a key figure in the field.
Collaborations
Aiko collaborates with notable colleagues, including Yasuhiro Shiba and Hiroki Yoshioka. Their combined expertise enhances the research and development efforts at Oncotherapy Science, Incorporated.
Conclusion
Aiko Kudo's innovative work in developing anti-CDH3 antibodies represents a significant advancement in cancer therapy. Her contributions are vital for improving treatment options for patients suffering from various cancers.